1832 Asset Management L.P.

Position in ARGX — Argenx SE

CIK 944388 TORONTO, A6

Position in ARGX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$61,487,050

-$31,606,115 QoQ

Shares Held

84,200

-23.9% QoQ

Ownership

0.135%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

1832 Asset Management L.P. holds $136,938,098 across 8 Biotechnology names. ARGX ranks #1 (44.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE This page	84,200	$61,487,050
2	BBIO	BridgeBio Pharma, Inc.	356,400	$26,466,264
3	AXSM	Axsome Therapeutics, Inc.	143,800	$24,305,076
4	KRYS	Krystal Biotech, Inc.	42,600	$11,004,432
5	INCY	Incyte Corp	74,053	$6,969,868
6	INSM	INSMED Inc	28,900	$4,725,728
7	REGN	Regeneron Pharmaceuticals, Inc.	2,000	$1,545,280
8	EPRX	Eupraxia Pharmaceuticals Inc.	60,000	$434,400

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$61,487,050	84,200	-23.9%	Shares	Sole	2026-05-14
2025-12-31	$93,093,165	110,700	0.0%	Shares	Sole	2026-02-13
2025-09-30	$81,647,892	110,700	-35.8%	Shares	Sole	2025-11-14
2025-06-30	$95,030,328	172,400	-5.9%	Shares	Sole	2025-08-13
2025-03-31	$108,488,854	183,300	-11.6%	Shares	Sole	2025-05-14
2024-12-31	$127,489,500	207,300	+38.8%	Shares	Sole	2025-02-14
2024-09-30	$80,932,544	149,300	-30.5%	Shares	Sole	2024-11-13
2023-09-30	$105,602,124	214,800	-2.5%	Shares	Sole	2023-11-13
2023-06-30	$85,818,546	220,200	0.0%	Shares	Sole	2023-08-14
2023-03-31	$82,042,116	220,200	-0.5%	Shares	Sole	2023-05-12
2022-12-31	$83,797,196	221,200	+22.3%	Shares	Sole	2023-02-15
2022-09-30	$63,831,440	180,800	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.